Gene expression data of trial drug Dehydroabietylamine derivative-2 (DAAD-2) for Sensitive (HEP3B) and resistant (SNU449) hepatocellular carcinoma (HCC) cell lines with controls

GSE88812

Homo sapiens

12 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

Hepatocellular carcinoma (HCC) is a highly prevalent and deadly disease world-wide. The survival of HCC patients is usually very poor due to the lack of efficient anti-cancer drugs

PubMed ID

27842576

Publication Title

Synthesis and bio-molecular study of (+)-N-Acetyl-α-amino acid dehydroabietylamine derivative for the selective therapy of hepatocellular carcinoma.

Total Samples

Submitter’s Institution

PHRC

Authors

Mustufa MA, Ozen C, Hashmi IA, Aslam A, Baig JA, Yildiz G, Muhammad S, Solangi IB, Ul Hasan Naqvi N, Ozturk M, Ali FI

Source Repository

Gene Expression Omnibus (GEO)

No rows found